|
|
||||||||
3 liquid stools/day, 11 of 61 versus 11 of 66; P = not significant) and was a marker for low CD4 cell count (median = 124/µL versus 212/µL in Cryptosporidium-negative patients; P < 0.04). Cryptosporidium hominis was the predominant species in this region and was associated with a longer duration of symptoms, a higher rate of asymptomatic infection, and a lower CD4 cell count versus C. parvum-infected patients (P < 0.05). This study suggests there may be important differences in the natural history of Cryptosporidium infection in HIV-infected persons depending on parasite species.
Received June 23, 2004. Accepted for publication November 11, 2004.
Acknowledgments: We thank Edward Mushi, Sr., Ruwaichi Uiso, and the other nurses involved in this study; Stanislaus Siriwa, Richard Tarimo, and Eline Ngomuo and the other clinical laboratory technicians; and all the patients who participated in this work. We also thank Dr. William Petri (University of Virginia) for helpful discussions and David Lyerly (Techlab, Inc.) for the E. histolytica II ELISA kits.
Financial support: This study was supported by the National Institutes of Health (grant U19 AI056872-01) and the Virginia Commonwealth Technology Research Fund.
Disclosure: None of the authors has a commercial or other association that might pose a conflict of interest.
* Address correspondence to Eric R. Houpt, Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, MR4 Building Room 2144, Charlottesville, VA 22908-1340. E-mail: erh6k{at}virginia.edu
Authors addresses: Eric R. Houpt, Oluma Y. Bushen, Anita Kohli, Amon Asgharpour, Cherie T. Ng, and Richard L. Guerrant, Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, MR4 Building Room 2144, Charlottesville, VA 22908-1340, Telephone: 434-243-9326, Fax: 434-924-0075, E-mails: erh6k{at}virginia.edu, ob3d{at}vurginia.edu, ak7t{at}virginia.edu, aa3z{at}virginia.edu, ctn8d{at}virginia.edu, and rlg9a{at}virginia.edu. Noel E. Sam, Venance Maro, Sendui Ole-Nguyaine, and John F. Shao, Kilimanjaro Christian Medical Centre, Moshi, Tanzania, E-mails: nsam{at}kcmc.ac.tz, venmaro{at}yahoo.co.uk, solengudr{at}yahoo.com, and jshao{at}kcmc.ac.tz. David P. Calfee, Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10029, E-mail: David.Calfee{at}msnyuhealth.org.
This article has been cited by other articles:
![]() |
A. R. Jex, A. Pangasa, B. E. Campbell, M. Whipp, G. Hogg, M. I. Sinclair, M. Stevens, and R. B. Gasser Classification of Cryptosporidium Species from Patients with Sporadic Cryptosporidiosis by Use of Sequence-Based Multilocus Analysis following Mutation Scanning J. Clin. Microbiol., July 1, 2008; 46(7): 2252 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pantenburg, S. M. Dann, H.-C. Wang, P. Robinson, A. Castellanos-Gonzalez, D. E. Lewis, and A. C. White Jr. Intestinal Immune Response to Human Cryptosporidium sp. Infection Infect. Immun., January 1, 2008; 76(1): 23 - 29. [Full Text] [PDF] |
||||
![]() |
S. E. Stroup, S. Roy, J. Mchele, V. Maro, S. Ntabaguzi, A. Siddique, G. Kang, R. L. Guerrant, B. D. Kirkpatrick, R. Fayer, et al. Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes. J. Med. Microbiol., September 1, 2006; 55(Pt 9): 1217 - 1222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |